2011 News
December 2011: Professor Sue Welburn appointed Assistant Principal Global Health
Congratulations to Professor Susan Welburn on her appointment as Assistant Principal Global Health, responsible for progressing the University's strategic objectives and developing University policy.
December 2011: Paper published in Biosensors & Bioelectronics
Development of immunosensors for direct detection of three wound infection biomarkers at point of care using electrochemical impedance spectroscopy
The above paper has been published in Biosensors and Bioelectronics
October 2011: Paper Published in Analyst
Alkaline phosphatase enzymatic signal amplification for fast, sensitive impedimetric DNA detection
The above paper was published online in Royal Society of Chemistry journal Analyst on 19th October. First author: Miriam Kaatz, senior author: Till Bachmann, Division of Pathway Medicine.
DOI: 10.1039/C1AN15767A
August 2011: DEP paper is in top 20 downloads in Biomicrofluidics
Dielectric manipulation of ribosomal RNA selected for the July 1, 2011 issue of Virtual Journal of Biological Physics Research
The paper, listed as a "Research Highlight", is among the top 20 downloads from the journal and is authored by Dr Gerard Giraud and staff from the Division of Pathway Medicine and the Schools of Physics, Chemistry, and Engineering at the University of Edinburgh.
Biomicrofluidics 5, 024116 (2011); doi:10.1063/1.3604395
September 2011: Paper published in Analytical and Bioanalaytical Chemistry
Fast DNA and protein microarray tests for the diagnosis of hepatitis C virus infection on a single platform
The above paper was published online on Thursday 1st September. Lead authors are Stuart Ember and Dr Holger Schulze, Division of Pathway Medicine
DOI 10.1007/s 00216-011-5332-5
New Investment for Fios Genomics
Fios Genomics Limited, a spin-out from the University of Edinburgh, has succeeded in completing an investment round of £500k, from a syndicate led by Archangel Informal Investments, which will allow expansion of its service capacity to meet the increasing demand from customers and to deliver industrial scale projects by strengthening the team and building new capabilities. The company has made two senior appointments, Dr Bill Buckie joins as CEO and Dr Sandy Primrose as non-executive chairman.
Fios Genomics was spun out in 2008 by Peter Ghazal, Tom Freeman, Thorsten Forster from the Division of Pathway Medicine and Anton Enright from the Wellcome Trust Sanger Institute and has been steadily generating revenues since that time. It's customers are from major pharma and biotech companies to academic, clinical and CRO's in UK, US, EU and Asia
July 2011: New European Diagnostic Clusters Alliance to be launched
The new European Diagnostic Clusters Alliance will be launched at the Euromediag International Convention in Montpellier on 7th July.
Dr Till Bachmann, Chief Operating Officer and Head of Biochip Research at the Division of Pathway Medicine, University of Edinburgh, is a founding member of the EDC Alliance.
The new alliance will strengthen networking at a European level to drive innovations in in-vitro diagnostics.
June 2011: Division of Pathway Medicine to collaborate with Smiths Detection Diagnostics
The Division of Pathway Medicine, University of Edinburgh, is to collaborate with Smiths Detection Diagnostics to develop an assay to detect antibiotic infections
April 2011: Welburn Group move in
The Division of Pathway Medicine welcomes Professor Sue Welburn and her group who have moved to Little France from their previous home in Summerhall.
This article was published on Feb 29, 2012